ISSCA Presents Regenerative Medicine World Congress and Promotes CGELL Technology Training

MIAMI, FL, April 2022 – The International Society for Stem Cell Application has announced plans to become a sponsor at this year’s IMCAS 2022 World Congress. From June 3rd to June 5th, 2022, dermatologists, plastic surgeons, and aesthetic practitioners will gather in Paris for the world’s largest aging science and aesthetic learning event. The International Society for Stem Cell Application (ISSCA) will be present, providing invaluable information about its innovative GCELL technology. Regenerative Medicine Certification program for physicians training and Promoting its Regenerative Medicine World Congress to be held in Istanbul turkey late September 

Cellular therapy is becoming standard practice in regenerative aesthetics due to its effectiveness and safety compared to existing treatment options Advanced technologies such as GCELL constitute a valuable therapeutic tool. Physicians specializing in dermatology, wound care, cosmetic gynecology, aesthetic medicine, hair transplants, and alopecia. Event participants will have a unique opportunity to learn about GCELL technology and ISSCA training programs 

. Interested IMCAS  attendees can visit the ISSCA and learn more about GCELL technology and ISSCA’s Regenerative Medicine World Congress at Booth 999  your spot, visit https://www.issca.us/world-congress/. 

Global Stem Cells Group is on the front line of advanced skin rejuvenation with a newly launched product.

MIAMI LAKES, Fla., April 4, 2022 – Global Stem Cells Group (GSCG) is proud to announce the launch of its new product with new lyophilized exosome technology.  Global Stem Cells Group’s new product line includes innovative anti-aging products that can regenerate cells and tissues in the body.

The new product, known as Cellgenic Lyophilized Exosomes, is derived from human umbilical cord mesenchymal stem cells and includes potent growth factors, peptides, coenzymes, minerals, amino acids, vitamins and UV radiation reducing agents for skin revitalization.

This new cutting-edge product is formulated with powerful growth factors to help combat aging skin, environmental damage and loss of elasticity and tone. It has been clinically tested for its effectiveness. This innovative skincare solution is easy to use and does not require any special shipping or storage requirements. It can be used as an add-on treatment with any other Global Stem Cells Group cosmetic products.

The exosome technology involves the freeze-drying of extracellular vesicles (EVs). These EVs are isolated from mesenchymal stem cell cultures that have been expanded in the laboratory. The Lyophilized Exosomes are then reconstituted with saline in front of the patient just before use.

It has been shown that these vesicles contain RNA, proteins and metabolites which promote wound healing, angiogenesis, tissue regeneration and anti-inflammatory effects when applied topically to the skin.

Global Stem Cells Group is on the front line of advanced skin rejuvenation. The company’s new product, Lyophilized Exosome, can be shipped anywhere in the world without refrigeration. This technology is a first for exosome preparation and will revolutionize the way that skin care professionals do business.

With offices in multiple countries around the globe, Global Stem Cells Group has become one of the fast-growing companies in its field. Now, with the launch of a new product, Lyophilized Exosomes, they are poised to continue that growth and solidify their position as a leader in advancing regenerative medicine worldwide.

“Our goal at Global Stem Cells Group is to develop the most effective regenerative products on the market,” said Benito Novas, CEO of Global Stem Cells Group. “Our new product line of lyophilized exosomes is a testament to our commitment to developing cutting edge products with great clinical utility.”

To learn more about Cellgenic Flow Exosomes, visit https://cellgenic.com/.

About Global Stem Cells Group

Global Stem Cells Group is a worldwide network of physicians and scientists dedicated to the advancement of stem cell therapies and regenerative medicine. It has developed a comprehensive stem cell therapy protocol that includes harvesting, processing, banking, and administering adult stem cells. Global Stem Cells Group administers a constant flow of knowledge and innovation regarding the role of stem cells in modern medicine. The company’s aim is to accelerate the process of getting promising stem cell research and technology developed into treatments and therapies, and made available to physicians and patients.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/

Media Contact:
Benito Novas
305-560-5337
info@stemcellsgroup.com

SOURCE Global Stem Cells Group

ISSCA is back for the second year in a row after a brief hiatus due to Covid with its annual ISSCA World Congress Of Regenerative Medicine 2022 for the Advancement of Cellular Therapies and Technology in Istanbul, Turkey.

[Istanbul, Turkey, 19/Jan/2022] —  The International Society for Stem Cell Applications, ISSCA, is again having the most anticipated regenerative medicine occasion of the year September 22-24, 2022. The non-profit association is celebrated worldwide for conveying the benefits of regenerative medicine to nations worldwide and nurturing an international congregation of world-class scientists and doctors from more than 35 countries via its conferences—the last of which took place on May 27-28th at the Pullman Istanbul Hotel & Convention Center.

The congress concentrates on getting physicians together from all over the world with three full days of conferences and workshops, such as the aesthetic applications workshop and the clinical applications workshop. Throughout this event, physicians and researchers speak with panels to discuss the recent advancements in the quickly expanding field of regenerative medicine; top among these are:

●       Molecular biology.

●       New models of treatment in surgical and cosmetic applications.

●       The latest technological advancements hit the area.

This conference includes a panel on Cellgenic Exosomes, which stems from years of progress towards discovering a regenerative medicine development to reduce harsh operating room time. The accumulation of this data serves one purpose– more effective treatment of degenerative disease worldwide with up-to-date therapeutic applications of stem cells.

Additionally, the conference also discusses the legal terrain for the practice of regenerative medicine as it offers itself around the world, meaning multiple national governments have input to some degree. Lectures are held over the course of the day at this congress, which is part of ISSCA’s mission to sustain a paradigm shift from conventional healthcare answers to regenerative medicine and deliver the latest ingenious findings and expansions in all areas of stem cell research.

The conference is held at the elegant Hotel Hyatt Regency, located near Istanbul’s Ataturk Airport. The hotel offers guests the medley of convenience, culture, and comfort while touring the ancient city, Turkey’s epicenter of entertainment and rich history. Congress attendees will uncover sceneries such as the Hagia Sophia and the Blue Mosque.

ISSCA Vice President Benito Novas had this to say about the conference: “It feels amazing to be back out– after so long with lockdowns and traveling difficulties, we were wondering if we would have to wait even longer to host an event. But, of course, it’s been far from ideal– even if the world locks down, research continues, and breakthroughs come through in our field of regenerative medicine month after month. Our ISSCA Congresses provide a great opportunity to spread this information out to the physicians who need it the most, and we plan to host as many as we can before the end of the year.”

Join the group of doctors looking for new alternatives for their patients by registering today to partake in ISSCA’s forthcoming events! Get ready to scale up your knowledge!

For more info, visit our website at https://www.issca.us/, email info@stemcellsgroup.com, or call +1305 560 5337.

 
About International Society for Stem Cells Applications

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary society of physicians and scientists aspiring to treat diseases through advances in science, tech, and regenerative medicine. ISSCA helps its members through advancements made to the specialty of regenerative medicine.

Regenerative medicine standards and certifications are critical, which is why ISSCA delivers certificate training worldwide. The objective is to inspire more doctors to practice regenerative medicine and open it globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

First-of-its-kind Cellular Therapy Training for doctors and medical practitioners in Pakistan

Newswise — Miami, FL –March 9th, 2022- The International Society for Stem Cell Applications (ISSCA) and Global Stem Cells Group (GSCG) today announced a new partnership with Ramzan Ali Syed Hospital  (RASC) to develop autologous bone marrow stem cell and exosome-based cell therapies and advance new therapeutic options for patients in the region. 

“Regenerative medicine is a fast-paced field that is growing exponentially every year as more and more research is being conducted and products are being used in clinics and doctors’ offices worldwide. -Said- Benito Novas  Managing director of the International Society for Stem Cell Applications. We are very proud to be able to collaborate with our hosts in Pakistan for the development of this medical specialty”. 

To stay abreast of current research, Ramzan Ali Syed Hospital partners with organizations like ISSCA and Global Stem Cells Group to provide continuing education opportunities for the doctors and specialists in Pakistan who want to learn more about how they can incorporate cellular therapies into their practice and help more patients with the latest generation of biologics and regenerative medicine products.

The first physician training course will be held in Lahore, Pakistan on March 30th – 31st & April 1st. Attendees will receive hands-on training on current protocols for MSC’s derived stem cell therapies, Exosomes, Bone Marrow derived stem cells, and PRP treatments as well as information about the most recent clinical applications with cellular medicine.

“This is the first time that ISSCA and Ramzan Ali Syed Hospital join forces for a stem cell certification course in the country, and this partnership will allow for more courses to be held in the future. This collaboration was born out of a desire to bring new technologies and cutting-edge treatments to patients throughout the country”. Said Dr. Mehmood Shaukat, Head of Pediatric Surgery 

“With Pakistan’s Ramzan Ali Syed Hospital as the newest member of the ISSCA community, we look forward to strengthening our relationship with the country and offering more support within the region,” said Benito Novas, CEO of the Global Stem Cells Group and Managing Director of ISSCA USA. “We know there is a lot of potential for cell therapies to have a huge impact here. Our goal is always to help patients and doctors have access to the best possible care, no matter where they live.”

Physicians looking to offer regenerative medicine treatments can benefit from the ISSCA and Ramzan Ali Stem Cell Center trainings, which are conveniently held onsite at the Ramzan Ali Syed Hospital, To learn more about the onsite training for doctors and other opportunities offered by ISSCA, visit https://www.issca.us

About ISSCA
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

About Ramzan Ali Syed Hospital 
Ramzan Ali Stem Cell Center is an all-inclusive healthcare facility in regenerative medicine located in the premises of Ramzan Ali Syed Hospital at 21 Temple Road, Lahore, Pakistan. It is a pioneering institution with a passion for the safety of all its patients. We will make sure to give you all the information you require to guide you in making better decisions for your health.

About GSCG
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/

The World Symposium on Stem Cells and Regenerative Medicine attracted a notable global audience interested in exploring the latest trends in regenerative medicine

MIAMI LAKES, Florida (December 22, 2021)—The International Society for Stem Cell Application (ISSCA), a multidisciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, recently hosted a two-day symposium in Córdoba, Argentina. Held on December 10-11, 2021, the symposium featured onsite and virtual attendance options, attracting a large global swath of physicians, medical specialists, surgeons, dentists, veterinarians, and other professionals interested in regenerative medicine. 

ISSCA hosted the event in conjunction with the support of the Argentine Society of Biological and Holistic Medicine (SAMByH) and the Global Stem Cells Group at the facilities of the Institute of Evolutionary and Biological Medicine (IMEB) in Río Cuarto. Eighty attendees were invited to attend the onsite symposium, while hundreds of additional attendees across the globe joined in virtually. 

The symposium featured a number of notable experts across the world sharing their insight and expertise on various emerging topics and trends in regenerative medicine. Topics included general cell biology concepts, treatment of various diseases and conditions using regenerative medicine, uses of regenerative practices in aesthetic medicine, and more. Attendees were able to gain additional insight through question-and-answer panels with symposium presenters. Throughout the two-day event, attendees also enjoyed networking opportunities.  

“The ISSCA is pleased to have collaborated with SAMByH and IMEB to bring the World Symposium on Stem Cells and Regenerative Medicine to the world. It was a resounding success, and we are thrilled that attendees took away valuable insight into the current state of and future projections for the world of regenerative medicine,” said Benito Novas, ISSCA Director. “Our goal is to help physicians and practitioners better treat their patients suffering from degenerative diseases by giving them the tools and education they need to implement regenerative protocols in their own practices. Our latest symposium has done just that, furthering the advancement of attendees’ knowledge and interest in the field as a viable treatment protocol for their patients.” 

“We are thrilled to have collaborated with the ISSCA in bringing this symposium to life,” said Dr. Alejandro Mazzarini, Director of IMEB. “It was exciting to share our facility and the important work we’re doing at IMEB with the world and have such a high caliber of attendees join us for this important event.” 

To learn more about the ISSCA’s latest news and innovations, visit https://www.issca.us/.

About ISSCA

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

December 24th, 2021: Stem Cell Center has opened a new location in Córdoba, Argentina. Looking to bring regenerative medicine technologies to Argentina, the grand opening of the center was attended by 80 attendees at the new IMEB facilities, and broadcast for viewers across Argentina and the rest of the world to stream online.

As a division of Global Stem Cells Group, Stem Cell Center is an international network of medical practices dedicated to bringing stem cell therapies to patients across the world. By uniting a group of medical practitioners in the field, they are able to provide training, equipment, and resources to practitioners who in turn offer research and knowledge to the community. As a group, they are continuously developing new treatments, making them available, and bringing the best possible care to patients in the pursuit of stem cell technology. 

The launch of the new facility brings the group one step closer to their shared goal of reducing human suffering across the world, now making strides to provide access to these medical technologies in Argentina. Each new launch contributes to the acceleration of the process of developing and translating stem cell research into treatments and therapies that are accessible to both patients and physicians. 

“Opening the center in Córdoba is a major step toward that goal, allowing us to give solutions to patients without drugs, instead manifesting the potential that lies within the body itself to trigger biological regeneration processes,” says Benito Novas, Founder of Global Stem Cells Group. This latest opening was made possible by a partnership and alliance between founder of Global Stem Cells Group, Benito Novas, and Director of IMEB, Doctor Luis Alejandro Mazzarini. 

“This inauguration marks the launch of the pursuit of regenerative medicine, cell therapy, and tissue engineering treatments in Córdoba,” says Benito Novas. “I founded the group in 2010, as an expert in marketing, life sciences, and healthcare development. At the time, I was interested in the new progress that was being made in the field and was eager to make them available to as wide an array of patients as possible across the world.” 

“We believe stem cell medicine is the future of the medical industry, and we work closely with regulators, policymakers, and medical professionals to foster this technology and harness the true potential.”

The seminal launch of this science, research and medical facility is one effort in the global mission of Stem Cell Center, who have announced a partnership with Bioscience Cell factory, offered training in Bolivia, and opened centers in Spain, Mexico, and Iraq. The global effort to reduce suffering is achieved one facility at a time, through the dedication of scientists, doctors, and researchers who believe in the untapped and often inaccessible potential of stem cell regenerative technology. 

To learn more about the Stem Cell Center, visit their website here: https://stemcellcenter.net/about/ 

 ISSCA About to Conduct Hands-On regenerative medicine training after the COVID-19. 

The COVID-19 pandemic has initiated a “new normal” of self-isolation, social distancing, and closed business. Due to this virus, the International Society for Stem Cell Application has been on hold. But, now the ISSCA is back in business. ISSCA is all set to begin the process of resuming the process of training courses. 

Florida (PRUnderground) May 19th, 2020

In these recent times, interest in the health of the immune system has increased. Due to this, both scientists and physicians are now turning towards strengthening regenerative medicine. The recent breakthroughs have led to a new program. In this program, a protocol is set to strengthen the immune system. This can further the ability of a person to fight and defend against various diseases. 

The training will take place in the city of Washington DC over the course of two days. In this training, we will be providing training to fiver doctors. The course will be about the latest regenerative medicine techniques. In this course, we will provide the physicians with all the tools they need to begin incorporating regenerative medicine in their practice.

The major goal of the International Society for stem cell application is to set the gold standards of regen medicine. ISSCA can accomplish this by hosting conferences and specialized certification courses, setting protocols, and publishing clinical research. Through this partnership, we are trying to spread knowledge on the current applications of cellular therapies. They can do this by building a platform for doctors to discuss the newest enhancements in the field. Various countries have held these conferences, and they work to make a globally recognized network of regenerative medicine practitioners and researchers.

About the International Society for Stem Cells Applications

ISSCA is a multidisciplinary community of skilled scientists and physicians who work to treat diseases and lessen human suffering. They do this through the advancements in science, the practice of regen medicine, and technology. ISSCA works under the Republic of Korea. It works as a non-profit organization. ISSCA focuses on promoting excellence and standards in the field of regenerative medicine. 

At ISSCA, the vision is to set high standards in the regenerative medicine fields. These fields can be publication, research, education, certification, and training. ISSCA has the aim to encourage more physicians and scientists to practice regenerative medicine.

GSCG Has Announced the Launch of Its New Division “BITA NOVAS”

The GSCG (Global Stem Cells Group) launches its new company VITA NOVAS in the famous field of regenerative medicine. VITA NOVAS is a professional mobile six infusion company. This company provides in-home treatments to patients to help them fight various infections, diseases, and viruses. Under the authority of GSCG, VITA NOVAS will launch in twenty-six countries. 

Due to the experience of GSCG, VITA NOVAS already has a foothold in this field. VITA NOVAS has an inherited reputation of quality, professionalism, skills, and innovation. The products of VITA NOVAS are basically Exosomes and Mesenchymal stem cells. This guarantees an effective and immediate way for the ingredients to be quickly available for the cells. Experts believe that this can reduce the time for the medication or supplements to take effect. 

The VITA NOVAS believes in the percept of Prevent-Protect-Thrive. Therefore, VITA NOVAS has set high standards in the industry. Besides this, they also provide service to patients at their homes. Apart from this, VITA NOVAS offers people infusion packages that mix with electrolytes, essential fluids, vitamins, and antioxidants. This way you can stimulate your immune system and help the immune system to bolster in fighting infections and diseases. Keeping the evolved life pattern of social distancing in mind, this is the process of treatment at VITA NOVAS: 

Select your Service Area

Receive the treatment at home

“We have combined elements of Tele-health with cellular therapy, IV wellness infusions, and a direct-to-consumer model intending to capitalize on the burgeoning market for medical services at the patient’s’ place of residence, due to convenience and social distancing practices,” explains Benito Novas, CEO of VITA NOVAS.

VITA NOVAS is a professional company. It has a program of provision of assistance and various prime incentives to professionals in the medical field. VITA NOVAS provides complete assistance to the new physician to help them set-up run, and market the practices. VITA NOVAS also creates a strong network for patient referrals, increased revenues, and conducts consultations from home. 

The Global Stem Cells Group or GSCG has a golden track and experience of more than a decade. GSCG is the parent company of six operating companies that dedicate to stem cell research, training, products, and solutions. Benito novas found GSCG in the year 2010. This company provides dedicated patients educators, physicians, researchers, and solution providers. These guys share the same goal of meeting the worldwide need for regenerative medicine treatments. The mission of GSCG is to make regenerative medicine the reality for patients around the globe. All of the six GSCG operating companies focus on a separate research-based mission. This results in a global network of state-of-the-art regenerative technology.

ISSCA About to Conduct Hands-On regenerative medicine training after the COVID-19.

The COVID-19 pandemic has initiated a “new normal” of self-isolation, social distancing, and closed business. Due to this virus, the International Society for Stem Cell Application has been on hold. But, now the ISSCA is back in business. ISSCA is all set to begin the process of resuming the process of training courses. 

Florida (PRUnderground) May 19th, 2020

In these recent times, interest in the health of the immune system has increased. Due to this, both scientists and physicians are now turning towards strengthening regenerative medicine. The recent breakthroughs have led to a new program. In this program, a protocol is set to strengthen the immune system. This can further the ability of a person to fight and defend against various diseases. 

The training will take place in the city of Washington DC over the course of two days. In this training, we will be providing training to fiver doctors. The course will be about the latest regenerative medicine techniques. In this course, we will provide the physicians with all the tools they need to begin incorporating regenerative medicine in their practice.

The major goal of the International Society for stem cell application is to set the gold standards of regen medicine. ISSCA can accomplish this by hosting conferences and specialized certification courses, setting protocols, and publishing clinical research. Through this partnership, we are trying to spread knowledge on the current applications of cellular therapies. They can do this by building a platform for doctors to discuss the newest enhancements in the field. Various countries have held these conferences, and they work to make a globally recognized network of regenerative medicine practitioners and researchers.

About the International Society for Stem Cells Applications

ISSCA is a multidisciplinary community of skilled scientists and physicians who work to treat diseases and lessen human suffering. They do this through the advancements in science, the practice of regen medicine, and technology. ISSCA works under the Republic of Korea. It works as a non-profit organization. ISSCA focuses on promoting excellence and standards in the field of regenerative medicine. 

At ISSCA, the vision is to set high standards in the regenerative medicine fields. These fields can be publication, research, education, certification, and training. ISSCA has the aim to encourage more physicians and scientists to practice regenerative medicine.

GSCG Has Announced the Launch of Its New Division “BITA NOVAS”

The GSCG (Global Stem Cells Group) launches its new company VITA NOVAS in the famous field of regenerative medicine. VITA NOVAS is a professional mobile six infusion company. This company provides in-home treatments to patients to help them fight various infections, diseases, and viruses. Under the authority of GSCG, VITA NOVAS will launch in twenty-six countries. 

Due to the experience of GSCG, VITA NOVAS already has a foothold in this field. VITA NOVAS has an inherited reputation of quality, professionalism, skills, and innovation. The products of VITA NOVAS are basically Exosomes and Mesenchymal stem cells. This guarantees an effective and immediate way for the ingredients to be quickly available for the cells. Experts believe that this can reduce the time for the medication or supplements to take effect. 

The VITA NOVAS believes in the percept of Prevent-Protect-Thrive. Therefore, VITA NOVAS has set high standards in the industry. Besides this, they also provide service to patients at their homes. Apart from this, VITA NOVAS offers people infusion packages that mix with electrolytes, essential fluids, vitamins, and antioxidants. This way you can stimulate your immune system and help the immune system to bolster in fighting infections and diseases. Keeping the evolved life pattern of social distancing in mind, this is the process of treatment at VITA NOVAS:

Select your Service Area

Receive the treatment at home

“We have combined elements of Tele-health with cellular therapy, IV wellness infusions, and a direct-to-consumer model intending to capitalize on the burgeoning market for medical services at the patient’s’ place of residence, due to convenience and social distancing practices,” explains Benito Novas, CEO of VITA NOVAS.

VITA NOVAS is a professional company. It has a program of provision of assistance and various prime incentives to professionals in the medical field. VITA NOVAS provides complete assistance to the new physician to help them set-up run, and market the practices. VITA NOVAS also creates a strong network for patient referrals, increased revenues, and conducts consultations from home. 

The Global Stem Cells Group or GSCG has a golden track and experience of more than a decade. GSCG is the parent company of six operating companies that dedicate to stem cell research, training, products, and solutions. Benito novas found GSCG in the year 2010. This company provides dedicated patients educators, physicians, researchers, and solution providers. These guys share the same goal of meeting the worldwide need for regenerative medicine treatments. The mission of GSCG is to make regenerative medicine the reality for patients around the globe. All of the six GSCG operating companies focus on a separate research-based mission. This results in a global network of state-of-the-art regenerative technology.